Literature DB >> 15663601

Cleavage of integrin by mu-calpain during hypoxia in human endometrial cells.

Kazufumi Aoyama1, Yasuhiko Ozaki, Tamao Nakanishi, Mayumi S Ogasawara, Katsuo Ikuta, Koji Aoki, Klas Blomgren, Kaoru Suzumori.   

Abstract

PROBLEM: The distribution and activation of mu-calpain and possible cleavage of integrin in human endometrial cells under hypoxic condition were investigated. METHOD OF STUDY: Human endometrial epithelial and stromal cells were subjected to hypoxia, and subsequently used for immunostaining and western blot analysis.
RESULTS: The proform of mu-calpain was detected in the cytoplasm of normal cells, and displayed a substantial decrease after hypoxia. Conversely, the active form of mu-calpain was not detected in normal cells, but was abundant after hypoxia. The cytoplasmic domain of integrin beta3 was also detected in the cytoplasm of endometrial cells. Western blot analysis confirmed that both the proform of mu-calpain and the integrin beta3 cytoplasmic domain decreased during hypoxia.
CONCLUSIONS: Mu-calpain is activated in human endometrial cells during hypoxia and that subsequent cleavage of the integrin beta3 cytoplasmic domain may give some adverse effects to the function of human endometrium. (c) Blackwell Munksgaard, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15663601     DOI: 10.1111/j.1600-0897.2004.00236.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  2 in total

Review 1.  The impact of hypoxia on intestinal epithelial cell functions: consequences for invasion by bacterial pathogens.

Authors:  Nathalie E Zeitouni; Sucheera Chotikatum; Maren von Köckritz-Blickwede; Hassan Y Naim
Journal:  Mol Cell Pediatr       Date:  2016-03-22

2.  Hypoxia Decreases Invasin-Mediated Yersinia enterocolitica Internalization into Caco-2 Cells.

Authors:  Nathalie E Zeitouni; Petra Dersch; Hassan Y Naim; Maren von Köckritz-Blickwede
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.